Omega Laboratories First to Receive FDA Clearance for Extended Opiates Test

Omega Laboratories is the first and only laboratory to receive 510(k) clearance from the FDA for its Extended Opiates Test that can detect the use of oxycodone, hydrocodone, codeine, morphine and heroin through human hair analysis, according to a news release.

Extended opiate testing using hair samples is becoming more popular including at companies regulated by Federal Guidelines. These companies, which often have safety-sensitive positions, such as motor carriers, pipeline/energy, nuclear power and railroads, conduct expanded drug testing programs under company authority. The extended testing program is more accurate than urine based testing programs.

Related Articles on Pain Management:

Ziconotide Recommended as First Treatment for Neuropathic and Nociceptive Chronic Pain
Dr. Jack D'Angelo: Patient Safety is Key When Preventing Opioid Abuse
Tennessee Requires Pain Management Clinics to Register with State

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast